Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio and Clinicopathological Factors in a Multicenter Cohort of Urothelial Carcinoma Treated with Adjuvant Nivolumab. (PubMed, Urol Int) - Oct 6, 2026 - "Baseline NLR and advanced pT stage serve as valuable independent prognostic factors for patients receiving adjuvant nivolumab. Although interpreted with caution regarding specific subgroups and retrospective limitations, these findings highlight key risk factors in this setting and provide a rationale for larger prospective validation."
Journal • Oncology • Solid Tumor • Urothelial Cancer
|
|
Asuka Sano; Daisuke Motoyama; Gaku Ishikawa; Hirofumi Morinaka; Hiromitsu Watanabe; Kazutoshi Fujita; Keita Tamura; Kiyoshi Takahara; Kyohei Watanabe; Kyosuke Nishio; Masanobu Saruta; Ryoichi Maenosono; Shinya Watanabe; Shunsuke Watanabe; Takafumi Yanagisawa; Teruo Inamoto; Wataru Fukuokaya; Yoshihiro Tsuchiya; Yuki Yoshikawa; Yutaka Yamamoto; Yuya Oishi
|